SPECTROSCOPIC DEFINITION OF THE GEOMETRIC AND ELECTRONIC-STRUCTURE OF THE NONHEME IRON ACTIVE-SITE IN IRON(II) BLEOMYCIN - CORRELATION WITH OXYGEN REACTIVITY

被引:73
作者
LOEB, KE
ZALESKI, JM
WESTRE, TE
GUAJARDO, RJ
MASCHARAK, PK
HEDMAN, B
HODGSON, KO
SOLOMON, EI
机构
[1] UNIV CALIF SANTA CRUZ,DEPT CHEM & BIOCHEM,SANTA CRUZ,CA 95064
[2] STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305
[3] STANFORD UNIV,SYNCHROTRON RADIAT LAB,STANFORD,CA 94305
关键词
D O I
10.1021/ja00121a013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The geometric and electronic structure of high-spin ferrous complexes of bleomycin (Fe(II)BLM) and the structural analog PMAH ([Fe(II)PMA](+), where PMAH is a macrocyclic ligand with pyrimidine, imidazole, deprotonated amide, and secondary and primary amine functionalities) have been investigated by optical (Abs) and X-ray (XAS) absorption, magnetic circular dichroism (MCD), and resonance Raman (rR) spectroscopies. From the excited state ligand field transition energies in the low-temperature MCD spectra, the XAS pre-edge shapes and intensities, and EXAFS analysis, solid [Fe(II)PMA](+) has been determined to have a five-coordinate, square-pyramidal geometry (E(dx2-y2) - E(dz2) = 6100 cm(-1)) with a short Fe-N bond (1.93 Angstrom), while in solution [Fe(II)PMA](+) binds a solvent molecule at the sixth position to form a distorted octahedral complex (E(dx2-y2) - E(dz2) = 2110 cm(-1)) with an expanded coordination sphere which still maintains one short Fe-N bond (2.00 Angstrom). Similar spectral features consistent with a six-coordinate geometry (E(dx2-y2) - E(dz2) = 2650 cm(-1)) are also present for Fe(II)BLM in solution, suggesting parallel ligation to the Fe2+ center in [Fe(II)PMA](+) including one relatively short Fe-N bond (2.06-2.08 Angstrom). The magnetic field and temperature dependence of the MCD intensity reveals an unusually small zero-field-splitting of the S = 2, M(s) = +/- 2 non-Kramers doublet ground state of Fe(II)BLM and [Fe(II)PMA](+) in solution (delta = 2.4 cm(-1)) indicating a large splitting of the d pi orbitals (E(dxz,yz) - E(dxy) = 800 and 950 cm(-1), respectively) resulting from strong metal-ligand pi-bonding interaction. The presence of moderately-intense, low-energy metal-to-ligand charge transfer (MLCT) transitions in the low-temperature Abs and MCD spectra of [Fe(II)PMA](+) and Fe(II)BLM represents an important deviation from other non-heme iron centers and reflects high covalency. The MLCT transition energies and intensities determine the degree of metal-ligand pi-backbonding which decreases along the series solid [Fe(II)PMA](+) > solution [Fe(II)PMA](+) > Fe(II)BLM. Assignment of these bands as iron(II) --> pyrimidine MLCT transitions is derived from the strong resonance enhancement of the pyrimidine normal modes at 680, 744, 1519, and 1542 cm(-1) in the [Fe(II)PMA](+) Raman spectrum, thereby implicating pyrimidine as the specific ligand associated with the large d pi splitting and short Fe-N bond. This pyrimidine pi-backbonding mediates the electron density localized on the Fe2+ center which contributes to the unique chemistry of Fe(II)BLM relative to other non-heme iron sites. This includes its ability to bind pi-acceptor exogenous ligands resulting in the conversion to a low-spin state and its formation of a long-lived oxygen intermediate.
引用
收藏
页码:4545 / 4561
页数:17
相关论文
共 111 条
[1]  
Umezawa H., Maeda K., Takeuchi T., Oakami Y., J. Antibiot., 19, pp. 200-209, (1966)
[2]  
Umezawa H., Surhara Y., Takita T., Maeda K.J., Antibiot., 19, pp. 210-219, (1966)
[3]  
Umezawa H., Biomedicine, 18, pp. 459-475, (1973)
[4]  
Hutchinson F., Povirk L.F., Bleomycin: Chemical, Biochemical, and Biological Aspects, pp. 255-266, (1979)
[5]  
Chien M., Grollman A.P., Horwitz S.B., Biochemistry, 16, pp. 3641-3647, (1977)
[6]  
Kross J., Henner W.D., Haseltine W.A., Rodriquez L., Levin M.D., Hecht S.M., Biochemistry, 21, pp. 3711-3721, (1982)
[7]  
Fisher L.M., Kuroda R., Sakai T.T., Biochemistry, 24, pp. 3199-3207, (1985)
[8]  
Umezawa H., Pure Appl. Chem., 28, pp. 665-680, (1971)
[9]  
DeReimer L.H., Meares C.F., Goodwin D.A., Diamanti C.I., J. Med. Chem., 22, pp. 1019-1023, (1979)
[10]  
Stubbe J., Kozarich J.W., Chem. Rev., 87, pp. 1107-1136, (1987)